You are viewing: Asia Pacific Artificial Intelligence (AI) in Healthcare Market analysis

The Asia Pacific Artificial Intelligence (AI) in Healthcare Market was valued at $21.63 Million in 2025 and projected to reach to $110.61 Million by 2030, representing a compound annual growth rate of 38.6%. Asia Pacific is positioned as a global leader in AI healthcare adoption, with substantial investments in digital infrastructure and government support catalyzing market growth.

Asia Pacific Artificial Intelligence (AI) in Healthcare Market Trends and Insights

  • Asia Pacific is experiencing rapid digital transformation driven by increasing healthcare expenditure, growing patient populations, and government initiatives supporting AI integration across diagnostic, therapeutic, and administrative applications.
  • By 2030, Asia Pacific's AI in healthcare market is forecast to expand to $110.61 billion, reflecting a compound annual growth rate of 38.6% and underscoring the region's pivotal role in global healthcare innovation. The expansion of Asia Pacific's AI healthcare market is fueled by rising demand for precision medicine, chronic disease management, and operational efficiency in hospitals and clinics.
  • Asia Pacific countries are investing heavily in AI-powered diagnostic tools, predictive analytics, and robotic process automation to address healthcare workforce shortages and improve patient outcomes.
  • The convergence of advanced computing infrastructure, regulatory support, and venture capital funding positions Asia Pacific as a leader in healthcare AI deployment through 2030..

Key Market Statistics

  • CAGR (2025-2030) 38.6% CAGR
  • Market Size, 2025 ~USD 21.63 Million
  • Forecast, 2030 ~USD 110.61 Million
  • Geography Asia Pacific

Asia Pacific Artificial Intelligence (AI) in Healthcare Market Overview

Rapid Market Expansion :

Asia Pacific's AI in healthcare market is projected to grow from $21.63 billion in 2025 to $110.61 billion by 2030, representing a robust 38.6% CAGR, driven by digital health infrastructure investments and increasing adoption across the region.

Government-Led AI Integration :

Regional governments are actively supporting AI adoption through policy frameworks and funding initiatives, accelerating implementation in diagnostic imaging, drug discovery, and clinical decision support systems across hospitals and healthcare providers.

Large Patient Populations & Healthcare Demand :

Asia Pacific's growing and aging populations are creating unprecedented demand for healthcare services, making AI-powered solutions essential for improving diagnostic accuracy, reducing treatment costs, and enhancing patient outcomes at scale.

Digital Transformation Leadership :

The region is experiencing accelerated digital transformation with increasing healthcare expenditure, widespread adoption of electronic health records, and emerging fintech ecosystems supporting AI-enabled healthcare innovation and deployment.

Asia Pacific Artificial Intelligence (AI) in Healthcare Market Dynamics

  • The region's diverse healthcare systems are increasingly leveraging AI for diagnostic imaging, personalized medicine, and operational efficiency.
  • Major economies including China, Japan, and India are driving innovation through research initiatives and clinical implementations.
  • The convergence of rising healthcare costs, large patient populations, and technological advancement creates a compelling growth trajectory.
  • By 2030, Asia Pacific is expected to capture significant market share, with AI applications becoming integral to healthcare delivery across diagnostic, therapeutic, and administrative domains, establishing the region as a critical innovation hub for global healthcare AI solutions..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Healthcare Analytics

    Top Technologies
    • Machine Learning
    • Natural Language Processing (NLP)
    • Blood Pressure Monitors
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    Top Companies
    • Oracle Corporation
    • PHILIPS HEALTHCARE
    • Siemens healthineers
    • Zensar Technologies Limited
    • EPIC SYSTEMS CORPORATION

      Healthcare It

      Top Technologies
      • Computed Tomography (CT)
      • Machine Learning
      • Magnetic Resonance Imaging (MRI)
      • Natural Language Processing (NLP)
      • Predictive Analytics
      Top Companies
      • CERNER CORPORATION
      • PHILIPS HEALTHCARE
      • Oracle Corporation
      • GE HealthCare Technologies Inc.
      • Siemens healthineers

        Key Takeaways

        • Asia Pacific's AI in healthcare market is valued at $21.63 billion in 2025 and is projected to reach $110.61 billion by 2030, representing a 38.6% CAGR.
        • Asia Pacific is leveraging AI for diagnostic imaging, drug discovery, and personalized treatment plans to address regional healthcare challenges and improve clinical outcomes.
        • Government policies and digital health initiatives across Asia Pacific are accelerating AI adoption in hospitals, clinics, and research institutions.
        • Asia Pacific's large patient population, aging demographics, and rising chronic disease burden are key drivers of AI healthcare investment and innovation through 2030.

        Artificial Intelligence (AI) in Healthcare Market Report Scope

        Report Metric Details
        Base Year 2025
        Forecast Period 2025–2039
        Growth Rate CAGR of 38.6% from 2025 to 2039
        Market Size Base Year (Billions) ~USD 21.63 (2025)
        Revenue Forecast (Billions) ~USD 110.61 (2039)
        Segments Covered Offering, Function, Type, Technology, Application, Modality, Deployment Model, Tool, End User

        Asia Pacific Artificial Intelligence (AI) in Healthcare Market Report Segmentation

        9 segment dimensions are covered across the global market.

        By Offering

        • AI Technologies
        • Integrated Solutions
        • Niche/Point Solutions
        • Services

        By Function

        • Administrative
        • Data Management & Analytics
        • Diagnosis & Early Detection
        • Patient Engagement & Remote Monitoring
        • Pharmacy Management
        • Post-Treatment Surveillance & Survivorship Care
        • Treatment Planning & Personalization

        By Type

        • Ambulatory Care Centers
        • Asset Management
        • Auto Coding
        • Behavioral Therapy & Psychotherapy
        • Billing & Claims Management
        • Classification & Categorization
        • Compliance & Documentation
        • Convolutional Neural Networks (Cnn)
        • Customer Relationship Management
        • Cybersecurity
        • Deep Learning
        • Device Context
        • Diagnostic & Imaging Centers
        • Diagnostic Imaging
        • Diagnostics Imaging
        • Dosing & Administration
        • Drug Allergy Alerting
        • Drug Response Prediction
        • Eprescribing
        • Follow-Up & Long-Term Support
        • Fraud Detection & Risk Management
        • Generative Adversarial Networks (Gan)
        • Graph Neural Networks (Gnn)
        • Healthcare Assistance Robots
        • Healthcare Workflow Management
        • Home Healthcare Agencies & Assisted Living Facilities
        • Hospitals & Clinics
        • Immunotherapy
        • Intraoperative Guidance & Robotics
        • Ivd
        • Long-Term Outcome Prediction
        • Medication Management
        • Medication Reminders
        • Mental Health & Support Systems
        • Motion Synchronization & Auto Contouring
        • Other Administrative Functions
        • Other Deep Learning Tools
        • Other Diagnosis & Early Detection Functions
        • Other Healthcare Providers
        • Other Machine Learning Tools
        • Other ML Tools
        • Other Patient Engagement & Remote Monitoring Functions
        • Other Pharmacological Therapy Functions
        • Other Pharmacy Management Functions
        • Other Radiation Therapy Functions
        • Other Treatment Planning & Personalization Functions
        • Patient Education & Empowerment
        • Patient Eligibility & Authorization
        • Patient Registration & Scheduling
        • Pattern & Image Recognition
        • Personalized Treatment Planning
        • Pharmacies
        • Pharmacological Therapy
        • Pharmacy Audit & Analysis
        • Physical Context
        • Postoperative Analysis & Recovery
        • Pre-Screening
        • Precision Medicine & Genomic Analysis
        • Predictive Models For Treatment Response
        • Preoperative Imaging & 3D Modeling
        • Private Payers
        • Progress Monitoring & Feedback
        • Public Payers
        • Radiation Therapy
        • Real-Time Adaptive Treatment Delivery
        • Real-Time Patient Data Monitoring
        • Recurrence Monitoring
        • Recurrent Neural Networks (Rnn)
        • Reinforcement Learning
        • Relapse Prediction & Long-Term Management
        • Response & Side-Effect Prediction
        • Response Assessment & Quality Assurance
        • Risk Assessment & Patient Stratification
        • Sentiment Analysis
        • Speech Recognition
        • Supervised Learning
        • Supply Chain & Inventory Management
        • Surgical Therapy
        • Symptom Management & Virtual Assistance
        • Telehealth & Remote Patient Monitoring
        • Text Analytics
        • Treatment Recommendation Systems
        • Unsupervised Learning
        • User Context
        • Virtual Counseling & Chatbots
        • Workforce Management

        By Technology

        • Clinical Chemistry
        • Immunoassays
        • Molecular Diagnostics

        By Application

        • Biomarker Discovery & Analysis
        • Clinical Applications
        • Disease Interpretation & Report Analysis
        • Image Analysis & Interpretation
        • Image Captioning & Annotation
        • Image Reconstruction
        • Non-Clinical Applications
        • Other Diagnostic Imaging Applications
        • Other Ivd Applications

        By Modality

        • Computed Tomography (Ct)
        • Magnetic Resonance Imaging (Mri)
        • Nuclear Imaging (Pet & Spect)
        • Other Diagnostic Imaging Modalities
        • Ultrasound
        • X-Ray Imaging

        By Deployment Model

        • Cloud-Based Models
        • Hybrid Models
        • On-Premise Models

        By Tool

        • Computer Vision
        • Context-Aware Computing
        • Generative AI
        • Image Analysis
        • Machine Learning (ML)
        • Natural Language Processing (Nlp)

        By End User

        • Healthcare Payers
        • Healthcare Providers
        • Other End Users
        • Patients

        Target Audience

        • Healthcare Technology Vendors : AI software and platform providers need Asia Pacific market intelligence to identify adoption trends, competitive gaps, and regional customization requirements for diagnostic, therapeutic, and administrative healthcare solutions.
        • Healthcare Providers & Hospital Networks : Hospital systems and healthcare organizations across Asia Pacific require market insights to evaluate AI solution investments, benchmark peer adoption rates, and optimize clinical and operational implementations.
        • Investment & Private Equity Firms : Investors targeting healthcare AI opportunities in Asia Pacific need detailed market sizing, growth forecasts, and regional opportunity analysis to identify high-potential companies and sectors for funding and acquisition.
        • Government & Healthcare Policy Makers : Regional health ministries and policy bodies need market data to inform AI healthcare strategies, funding allocations, and regulatory frameworks that support innovation while ensuring equitable access across Asia Pacific.
        • Pharmaceutical & Biotech Companies : Drug developers and biotech firms require Asia Pacific AI market insights to understand AI-enabled drug discovery adoption, clinical trial optimization, and personalized medicine opportunities in the region's growing markets.

        Key Companies in the Asia Pacific Artificial Intelligence (AI) in Healthcare Market

        CompanyHQOwnershipStrongest segments
        EPAM SYSTEMS, INC.United States
        SIEMENS AGGermany
        WNS GLOBAL SERVICESIndia
        L&T TECHNOLOGY SERVICES LIMITEDIndia
        LARSEN & TOUBRO INFOTECH LIMITEDIndia
        SOPRA STERIAUnited States
        CYIENTIndia

        EPAM SYSTEMS, INC.

        EPAM Systems, Inc. is a leading digital transformation and software engineering services company headquartered in the United States. The company provides consulting, software development, and IT services to clients across various industries globally.

        SIEMENS AG

        Siemens AG is a German multinational conglomerate providing automation, digitalization, and electrification solutions across industrial, infrastructure, and mobility sectors worldwide.

        WNS GLOBAL SERVICES

        WNS Global Services is an India-based business process management and IT services company offering customer engagement, finance and accounting, and technology solutions to global enterprises.

        L&T TECHNOLOGY SERVICES LIMITED

        L&T Technology Services Limited is an India-based engineering and technology services company providing design, engineering, and digital transformation solutions across multiple industries.

        LARSEN & TOUBRO INFOTECH LIMITED

        Larsen & Toubro Infotech Limited is an India-based IT services and consulting company offering digital transformation, cloud, and enterprise solutions to global clients.

        SOPRA STERIA

        Sopra Steria is a digital services and software company providing consulting, systems integration, and software development services, with operations in the United States and globally.

        CYIENT

        Cyient is an India-based engineering and technology services company specializing in digital, engineering, and cloud solutions for aerospace, defense, and industrial sectors.

        Asia Pacific vs. other regions

        HowAsia Pacific compares to the other 3 regional blocs covered in this market.

        Global
        ~USD 110.61 Million · 38.6% wtd CAGR ·
        North America
        ~USD 110.61 Million · 38.6% wtd CAGR ·
        Europe
        ~USD 110.61 Million · 38.6% wtd CAGR ·
        Latin America
        ~USD 110.61 Million · 38.6% wtd CAGR ·
        Middle East & Africa
        ~USD 110.61 Million · 38.6% wtd CAGR ·

        Countries within Asia Pacific - compare and drill down

        Country2025 size (native)
        ChinaUSD 9049.8 Million
        JapanUSD 7171.8 Million
        IndiaUSD 4529 Million

        Country market size visualization

        China
        USD 9049.8 Million
        Japan
        USD 7171.8 Million
        India
        USD 4529 Million

        Reasons to Buy this Report

        • Regional Market Sizing & Forecasts : Obtain precise market valuations for Asia Pacific ($21.63B in 2025) with country-level breakdowns for China, Japan, and India, enabling accurate budget allocation and investment planning specific to regional opportunities.
        • Competitive Landscape Intelligence : Identify leading AI healthcare providers, emerging startups, and technology partnerships within Asia Pacific to benchmark competitive positioning and discover collaboration or acquisition opportunities in high-growth markets.
        • Government Policy & Regulatory Insights : Understand regional regulatory frameworks, government incentives, and healthcare AI mandates across Asia Pacific countries, critical for market entry strategies and compliance planning in diverse regulatory environments.
        • Application-Specific Growth Drivers : Analyze which AI applications (diagnostic imaging, drug discovery, clinical analytics) are driving growth in Asia Pacific, enabling targeted product development and go-to-market strategies aligned with regional demand.
        • Investment & Partnership Opportunities : Discover high-potential markets, healthcare provider networks, and technology ecosystems within Asia Pacific for strategic partnerships, joint ventures, and capital deployment in the fastest-growing healthcare AI region globally.

        Frequently asked questions

        What is the current market size of AI in healthcare in Asia Pacific?

        Asia Pacific's AI in healthcare market is estimated at $21.63 billion in 2025 and is expected to grow to $110.61 billion by 2030.

        What is the projected growth rate for AI in healthcare across Asia Pacific?

        Asia Pacific's AI in healthcare market is projected to grow at a compound annual growth rate (CAGR) of 38.6% from 2025 to 2030.

        Which applications of AI are driving growth in Asia Pacific's healthcare market?

        Asia Pacific is seeing significant adoption of AI in diagnostic imaging, predictive analytics, drug discovery, robotic process automation, and personalized medicine applications.

        What factors are accelerating AI adoption in Asia Pacific healthcare?

        Key drivers include rising healthcare expenditure, government digital health initiatives, workforce shortages, aging populations, chronic disease prevalence, and increased venture capital investment in Asia Pacific.

        How does Asia Pacific's AI healthcare market compare to other regions?

        Asia Pacific is one of the fastest-growing regions for healthcare AI, with a 38.6% CAGR reflecting strong regional demand, supportive policies, and significant market expansion potential through 2030.

        RESEARCH METHODOLOGY

        The study involved significant efforts to estimate the current size of the artificial intelligence (AI) in healthcare market. Exhaustive secondary research was conducted to collect information on the artificial intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the artificial intelligence (AI) in healthcare market.

        Secondary Research

        This research study involved the extensive use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and Companies House documents; investor presentations; and companies' SEC filings. The market for companies offering artificial intelligence (AI) in healthcare solutions is derived from secondary data available through paid and unpaid sources, analysis of the product portfolios of major companies in the ecosystem, and ratings of companies based on performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, company investor presentations, white papers, journals, certified publications, articles by recognized authors, directories, and databases.

        Various secondary sources were consulted during the secondary research process to identify and collect information relevant to the study. These sources included annual reports, press releases, investor presentations of artificial intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. Secondary research was used to obtain critical information on the industry’s value chain, the pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.

        Primary Research

        In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess prospects.

        Primary research was conducted to identify segmentation types, key players, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategies adopted by key players.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimates, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived.

        In the complete market engineering process, top-down and bottom-up approaches, along with several data triangulation methods, were extensively used to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted on the complete market engineering process to identify key information/insights throughout the report.

        Artificial Intelligence in Healthcare Market 
 Size, and Share

        Note 1: Other designations include sales, marketing, and product managers.
        Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tool, end user, and region).

        Artificial Intelligence in Healthcare Market Top Down and Bottom Up Approach

        Data Triangulation

        After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the artificial intelligence (AI) in healthcare market.

        Market Definition

        The artificial intelligence (AI) in healthcare market encompasses the application of AI technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiency, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.

        Key Stakeholders

        • Artificial intelligence (AI) in healthcare software vendors
        • Artificial intelligence (AI) in healthcare service providers
        • Independent software vendors (ISVs)
        • Platform providers
        • Technology providers
        • System integrators
        • Cloud service providers
        • Healthcare IT service providers
        • Hospitals and surgical centers
        • Diagnostic imaging centers
        • Academic institutes and research laboratories
        • Forums, alliances, and associations
        • Government organizations
        • Institutional investors and investment banks
        • Investors/Shareholders
        • Venture capitalists
        • Research and consulting firms

        Report Objectives

        • To define, describe, and forecast the global artificial intelligence (AI) in healthcare market based on offering, function, application, deployment, tool, end user, and region
        • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
        • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall artificial intelligence (AI) in healthcare market
        • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
        • To forecast the size of the artificial intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
        • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
        • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the artificial intelligence (AI) in healthcare market
        • To benchmark players within the artificial intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.

        Available customizations:

        With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

        Company Information

        • Detailed analysis and profiling of additional market players (up to 5)

        Geographic Analysis

        • Further breakdown of the Rest of Europe artificial intelligence (AI) in healthcare market into Denmark, Norway, and others
        • Further breakdown of the Rest of Asia Pacific artificial intelligence (AI) in healthcare market into Vietnam, New Zealand, Australia, South Korea, and others

         

        Get the Full Artificial Intelligence (AI) in Healthcare Market Report

        Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Healthcare Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status